Home > Healthcare > Pharmaceuticals > Finished Drug Form > Orthobiologics Market

Orthobiologics Market Size

Report ID: GMI9311
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Orthobiologics Market Size

Orthobiologics Market size was valued at around USD 6.8 billion in 2023 and is estimated to grow at 5.7% CAGR from 2024 to 2032. The increasing prevalence of orthopedic disorders is a key driver in the market growth.

To get key market trends

Download Free Sample

As the global population ages and lifestyle become more sedentary, the incidence of orthopedic conditions such as osteoarthritis, fractures, and musculoskeletal injuries is on the rise. Sports-related injuries, trauma, and obesity contribute to the growing burden of orthopedic disorders worldwide.

For instance, according to the American Academy of Orthopaedic Surgeons (AAOS), the prevalence of osteoarthritis in the U.S. continues to rise. A study published in the Journal of Bone and Joint Surgery in 2021 reported that over 32 million adults are affected by osteoarthritis. These trends highlight the pressing need for effective treatments to alleviate pain, restore function, and promote healing in patients with orthopedic disorders, driving the demand for orthobiologics in the global market.

Orthobiologics Market Report Attributes
Report Attribute	Details
Base Year:	2023
Orthobiologics Market Size in 2023:	USD 6.8 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	5.7%
2032 Value Projection:	USD 11.4 Billion
Historical Data for:	2021 - 2023
No. of Pages:	100
Tables, Charts & Figures:	149
Segments covered:	Product Type, Application, End-use, and Region
Growth Drivers:	Increasing incidence of spinal disorders Surging cases of orthopedic and sports injuries Growing preference for minimally invasive procedures Increasing prevalence of various bone diseases
Pitfalls & Challenges:	High costs associated with orthobiologic-based treatments Clinical limitations of various orthobiologics

Learn more about the key segments shaping this market

Download Free Sample

Orthobiologics refers to substances that are used to help injuries and conditions related to bones and joints heal more quickly. These substances are typically made from substances that are naturally found in the body or are manufactured to mimic natural processes. Orthobiologics may include bone grafts substitutes, growth factors, stem cells, and other biologically active substances that stimulate bone and tissue regeneration.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Orthobiologics market size was valued at USD 6.8 billion in 2023 and is estimated to grow at 5.7% CAGR from 2024 to 2032, driven by the increasing prevalence of orthopedic disorders.

The hospitals and orthopedic clinics segment in the orthobiologics industry will generate USD 7.6 billion by 2032, due to the strong need for handling joint reconstruction devices, spinal fusion devices, and soft tissue repair.

North America orthobiologics market size accounted for USD 3 billion in revenue in 2023, owing to the prevalence of individuals participating in sports and physical activities and higher incidence of sports-related injuries.

Anika Therapeutics, Inc., Arthrex Inc., Bioventus LLC, Depuy Synthes (JnJ), Globus Medical Inc., Medtronic PLC, NuVasive Inc., Orthofix Medical Inc., RTI Surgical, Seaspine Holdings Corporation, Stryker Corporation and Zimmer Biomet